Spyre Therapeutics
SYRE
SYRE
31 hedge funds and large institutions have $42.9M invested in Spyre Therapeutics in 2017 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 11 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
3% less funds holding
Funds holding: 32 → 31 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
Holders
31
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.31M | |
| 2 | +$600K | |
| 3 | +$123K | |
| 4 |
Renaissance Technologies
New York
|
+$105K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$85K |
Top Sellers
| 1 | -$639K | |
| 2 | -$576K | |
| 3 | -$190K | |
| 4 |
SIM
Spark Investment Management
New York
|
-$165K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$86K |